<i>RIPK1</i> Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in MiceDenuja Karunakaran, Katey J. Rayner, Hailey Wyatt et al.|Circulation|2020Cited by 233
How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial InfarctionZachary Lister, Erik J. Suuronen, Katey J. Rayner|Frontiers in Bioengineering and Biotechnology|2016Cited by 24
Therapeutic inhibition of RIP1 improves metabolic dysfunction and inhibits atherosclerosis in mouse models of cardiometabolic diseasesDenuja Karunakaran, Katey J. Rayner, My Anh Nguyen et al.|The FASEB Journal|2018Cited by 1
Abstract 17409: Therapeutic Inhibition of RIP1 Improves Metabolic Dysfunction and Inhibits Atherosclerosis in Mouse Models of Cardiometabolic DiseasesDenuja Karunakaran, Katey J. Rayner, Michèle Geoffrion et al.|Circulation|2017Cited by 0